Thymosin beta-4 directs cell fate determination of human mesenchymal stem cells through biophysical effects

Jennifer H. Ho, Wei Hsien Ma, Yeu Su, Kuang Ching Tseng, Tom K. Kuo, O. K S Lee

研究成果: 雜誌貢獻文章同行評審

24 引文 斯高帕斯(Scopus)


Change of actin filament organization at the early stage of cell differentiation directs cell fate commitment of mesenchymal stem cells (MSCs). Thymosin beta-4 (Tβ4), a major G-actin sequestering peptide, is known to regulate the cytoskeleton. The study investigated the ways in whichTβ4 regulates cell fate determination inMSCsupon differentiation induction. It was found thatTβ4 decreased F-actin formation, reduced the F-actin/G-actin ratio, and inhibited osteogenic differentiation; such actin reorganization was not associated with the change of Runt-related transcription factor 2 gene expression during early osteogenic induction. Besides, Tβ4 reciprocally facilitated adipogenic differentiation. Tβ4 treatment was found to up-regulate gene as well as promote surface expression of adipocyte adhesion molecule during early adipogenic differentiation, which accompanied acceleration of adipocyte phenotypic maturation but was not associated with differential expression of peroxisome proliferator-activated receptorgammaduring the first week of adipogenic induction. In summary, Tβ4 initiated cell fate determination of MSCs through biophysical effects exerted by cytoskeleton reorganization and altered cellcell adhesion rather than direct regulation of lineage-determining transcriptional factors. Such findings suggest that Tβ4, a ubiquitous peptide, may be involved in osteoporosis when its intracellular concentration is elevated. Further investigation of targeting Tβ4 for future osteoporosis treatment is warranted.

頁(從 - 到)131-138
期刊Journal of Orthopaedic Research
出版狀態已發佈 - 1月 2010

ASJC Scopus subject areas

  • 骨科和運動醫學


深入研究「Thymosin beta-4 directs cell fate determination of human mesenchymal stem cells through biophysical effects」主題。共同形成了獨特的指紋。